OMB Control No. 0920-0900
Rubella Air Contact Investigation Outcome Reporting Form
FAX completed form to the CDC at 404.718.2158; For questions, call 404.639.7147
	
| 
 | |||||||
| CDC/QARS ID# | Arrival date | Departure city/airport | Arrival city/airport | Index case row | |||
| 
			 
 | 
			 | 
			 | 
			 | 
			 | |||
| 2. Index case clinical AND lab information | |||||||
| 
			 
 
 | |||||||
| 3. Contact Information | |||||||
| Last name, First name | Assigned seat | Gender | DOB (mm/dd/yyyy)/Age (yrs) | ||||
| 
			 
 | 
			 | 
			 | 
			 | ||||
| 4. Contact/Interview information | |||||||
| 
			 Were you able to contact this person?  No, why not?  Incorrect locating information  No longer at temporary address but still in the U.S.  No response  Returned to country of residence  HD didn’t attempt follow-up  Other, specify ___________ (Stop here)  Yes, date contacted: ___/___/___ Was contact interviewed?  No, why not?  Declined  Lives in different jurisdiction, specify _________________  Other, specify ________________________________________________ (Stop here)  Yes; Actual/verified seat #__________ 
 Was this person a known close contact of the index case outside of this flight (e.g. family member)?  No  Yes | |||||||
| 5. immunity | |||||||
| 
			 MMR (or other rubella-containing vaccine) or history of disease:  Not vaccinated  One dose of vaccine  Two doses of vaccine  Three doses of vaccine  Immunized, number of doses unknown  History of disease  Immunity established by serology  Unknown | |||||||
| 6. Rubella intervention related to exposure on the flight | |||||||
| 
			 Did contact receive intervention for this exposure to rubella (not routinely recommended)?  No  Yes, please indicate what s/he received and the date:  Immunoglobulin; Date received: ___/___/___  Other, specify ______________________________________________ Reason for intervention: _______________________________________________________________________________ 
 | |||||||
| 7. health since flight | |||||||
| 
			 Is this person pregnant?  No  N/A  Yes; what trimester at time of the flight?  1st  2nd  3rd 
 Did contact report any signs or symptoms of rubella?  No (Stop here)  Yes If yes, check all that apply:  Fever (Max temp measured ______oC/F)  Rash  Cough  Coryza  Conjunctivitis  Lymphadenopathy  Arthritis/arthralgia | |||||||
| 8. DIAGNOSIS | |||||||
| 
			 Was this person diagnosed with rubella?  No  Unknown, why?  Declined medical evaluation  Not interviewed after incubation period (max of 23 days after flight)  Lost to follow-up  Other, specify ___________________________________________  Yes, how was diagnosis made? (Check all that apply)  IgM  Paired IgG  PCR  Culture  Epi-linked  Clinical diagnosis  Other, specify______________ 
 Check any of the following potential rubella exposures this person may have had in the 23 days prior to symptom onset:  Visited/lives in a country with endemic rubella  Exposed to a confirmed rubella case besides the index case on the flight  Other, specify ______________________________________________ 
 | |||||||
| 9. COMMENTS | |||||||
| 
			 
 
 | |||||||
Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA 0920-0900.
	
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document | 
| File Title | Standard TB and Air Travel Contact Investigation Outcome Reporting Form for CDC | 
| Author | Kqm5 | 
| File Modified | 0000-00-00 | 
| File Created | 2021-01-24 |